Professional Summary
Professional Overview
Michelle Johnson is a seasoned finance executive with over 20 years of experience in the biotechnology and pharmaceutical industries. As the Vice President of Finance at Rapport Therapeutics, she oversees the company's financial operations, strategic planning, and investor relations, playing a crucial role in driving the organization's growth and success.
Experience Summary
Current Role
As the Vice President of Finance at Rapport Therapeutics, Michelle is responsible for leading the company's financial strategy, reporting, and analysis. She works closely with the executive team to align financial objectives with the overall business goals, ensuring efficient resource allocation and financial risk management. Under her leadership, Rapport Therapeutics has achieved significant milestones, including securing funding for key research and development initiatives.
Career Progression
Prior to her current role, Michelle held senior finance positions at various biotechnology companies, including Affinivax Inc. and Agios Pharmaceuticals. As the Senior Director and Head of FP&A at these organizations, she was instrumental in driving financial planning, budgeting, and forecasting processes, enabling informed decision-making and strategic planning. Earlier in her career, Michelle gained valuable experience in finance and accounting roles at Biogen and Dell, Inc., where she honed her skills in financial reporting, treasury management, and revenue accounting.
Academic Background
Michelle holds a Bachelor of Business Administration degree in Accounting from the University of Texas at Austin. She is a Certified Public Accountant (CPA) and is committed to ongoing professional development, attending industry conferences and workshops to stay up-to-date with the latest trends and best practices in finance and biotechnology.
Areas of Expertise
- Financial planning and analysis
- Strategic financial management
- Budgeting and forecasting
- Investor relations and fundraising
- Financial reporting and compliance
- Risk management and control
- Biotechnology and pharmaceutical industry expertise
Professional Impact
Throughout her career, Michelle has demonstrated a track record of driving financial excellence and aligning financial strategies with business objectives. At Rapport Therapeutics, she has played a pivotal role in securing funding for key research initiatives, optimizing financial processes, and enhancing the company's financial reporting capabilities. Her industry knowledge, strategic mindset, and collaborative approach have earned her the respect of her peers and the trust of the executive team.
Conclusion
With her extensive experience in the biotechnology and pharmaceutical industries, Michelle Johnson is a highly-capable finance leader poised to make a significant impact at Rapport Therapeutics. Her expertise in financial planning, strategic management, and investor relations positions her as a valuable asset to the organization as it navigates the dynamic healthcare landscape and pursues its ambitious growth objectives.
